19 Sep, 2024 EU Parliament Adopts Position on Pharmaceutical Reform: implications for the Environmental Risk Assessment By Emma Stok Hester Borgers In our earlier article, we discussed the implications of the European Commission’s legislative proposal from 26 April 2023 for the...
17 Sep, 2024 The DNA of Life Sciences Deals By James Baillieu Maria John The life sciences sector, comprising of sub-sectors like pharmaceuticals, medical devices, diagnostics and services, aims to cure disease...
11 Sep, 2024 EU Pharmaceutical Reform: Update on the proposed changes to marketing authorisation procedures By Sally Shorthose Sophie Vo This article is part of our series covering the proposed reforms to the EU pharmaceutical legislation. To view the entire series, click...